/PRNewswire/ HanAll Biopharma Co., Ltd. (KRX: 009420. KS), a global biopharmaceutical company committed to discovering and developing innovative medicines.
HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ HanAll Biopharma Co., Ltd. (KRX: 009420. KS), a global biopharmaceutical company committed to discovering and developing innovative medicines.
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer - read this article along with other careers information, tips and advice on BioSpace